The Central Drugs Standard Control Organization (CDSCO) has issued a Circular directing all retail and wholesale pharmacy stores across the country to prominently display a designated Pharmacovigilance Programme of India (PvPI) QR Code and a Toll-Free Number for reporting Adverse Drug Reactions (ADRs).
The decision, made during the 16th Working Group Meeting of the PvPI on June 18, 2025, is part of an ongoing commitment to strengthening patient safety and pharmacovigilance in India.
New Reporting Requirements for Pharmacies
The circular, dated November 20, 2025, instructs all State and Union Territory Drug Licensing Authorities to ensure strict compliance with the following directives:
QR Code Display
A designated PvPI QR Code (issued by the National Coordination Centre – Pharmacovigilance Programme of India) must be displayed at a prominent location within every retail and wholesale pharmacy premises.
Toll-Free Number
The PvPI toll-free number, 1800-180-3024, must be clearly displayed alongside the QR Code at each pharmacy outlet.
This measure is intended to facilitate the seamless reporting of Adverse Events/Adverse Drug Reactions (AE/ADRs) by the public and healthcare professionals through the indigenous PvPI Adverse Drug Reaction Monitoring System (ADRMS).
The Drugs Controller General (India) has requested immediate action for implementation and wide dissemination of these instructions among all license holders to promote drug safety and protect public health.
You may also be interested in:
NMC Mandates Medical Device Adverse Event Committees in All Medical Colleges
Draft In-vitro Diagnostic Medical Device Adverse Event Reporting
New Version Of Medical Device Adverse Event Reporting Form Released
Medical Device License Holders Urged to Report Adverse Events On MvPI Platform